Oxandrolone

Oxandrolone
Systematic (IUPAC) name
17β-hydroxy-17α-methyl-2-oxa-5α-androstan-3-one
Clinical data
AHFS/Drugs.com monograph
MedlinePlus a604024
Pregnancy
category
  • X
Legal status
Routes of
administration
Oral
Pharmacokinetic data
Bioavailability 97%
Metabolism Hepatic
Biological half-life 9 hours
Excretion Urinary:90%; Fecal:7%
Identifiers
CAS Number 53-39-4 YesY
ATC code A14AA08
PubChem CID 5878
IUPHAR/BPS 7092
DrugBank DB00621 YesY
ChemSpider 5667 YesY
UNII 7H6TM3CT4L YesY
KEGG D00462 YesY
ChEBI CHEBI:7820 YesY
ChEMBL CHEMBL1200436 N
Chemical data
Formula C19H30O3
Molar mass 306.44 g/mol
 NYesY (what is this?)  (verify)

Oxandrolone, also known as oxandrin, is a drug first synthesized by Raphael Pappo while at Searle Laboratories, now Pfizer Inc., under the trademark Anavar, and introduced into the United States in 1964. It is a synthetic anabolic steroid derivative of dihydrotestosterone with an oxygen atom replacing the 2 carbon and methylation in the 17 position.

Biological effects

In contrast with some other steroids with a methyl group in the 17-alpha position, the liver toxicity of oxandrolone is low. Studies have shown that a daily dose of 20 mg oxandrolone used in the course of 12 weeks had only a negligible impact on the increase of liver enzymes.[1][2] As a DHT derivative, oxandrolone does not aromatize, and thus does not cause gynecomastia. It also does not significantly influence the body's normal testosterone production (HPTA axis) at low dosages (20 mg). When dosages are high, the human body reacts by reducing the production of luteinizing hormone after perceiving endogenous testosterone production as too high; this in turn eliminates further stimulation of Leydig cells in the testicles, causing testicular atrophy.

In a randomized, double-blind study, patients with 40% total body surface area burns were selected to receive standard burn care plus oxandrolone, or without oxandrolone. Those treated with oxandrolone showed improved body composition, preserved muscle mass and reduced hospital stay time.[3]

History

The drug was prescribed to promote muscle regrowth in disorders which cause involuntary weight loss, and is used as part of treatment for HIV/AIDS. It had also been shown to be partially successful in treating cases of osteoporosis. However, in part due to bad publicity from its abuses by bodybuilders, production of Anavar was discontinued by Searle Laboratories in 1989. It was picked up by Bio-Technology General Corporation, now Savient Pharmaceuticals who, following successful clinical trials in 1995, released it under the tradename Oxandrin.

It was subsequently approved for orphan drug status by the Food and Drug Administration (FDA) for treating alcoholic hepatitis, Turner syndrome, and HIV-induced weight loss. It is also indicated as an offset to protein catabolism caused by long-term administration of corticosteroids. In addition, the drug has shown positive results in treating anemia and hereditary angioedema. Because of its potential for abuse, it is categorized as a Schedule III controlled substance in the United States.

References

  1. Schroeder ET, Zheng L, Yarasheski KE, Qian D, Stewart Y, Flores C, Martinez C, Terk M, Sattler FR (March 2004). "Treatment with oxandrolone and the durability of effects in older men". J. Appl. Physiol. 96 (3): 1055–62. doi:10.1152/japplphysiol.00808.2003. PMID 14578370.
  2. Grunfeld C, Kotler DP, Dobs A, Glesby M, Bhasin S (March 2006). "Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study". J. Acquir. Immune Defic. Syndr. 41 (3): 304–14. doi:10.1097/01.qai.0000197546.56131.40. PMID 16540931.
  3. Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, Herndon DN (September 2007). "The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn". Ann. Surg. 246 (3): 351–60; discussion 360–2. doi:10.1097/SLA.0b013e318146980e. PMC 1959346. PMID 17717439.

Further reading

External links

This article is issued from Wikipedia - version of the Monday, January 25, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.